Last $50.98 USD
Change Today -1.40 / -2.67%
Volume 2.4M
CTRX On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ GS
Berlin
As of 8:10 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

catamaran corp (CTRX) Snapshot

Open
$52.26
Previous Close
$52.38
Day High
$52.64
Day Low
$50.21
52 Week High
04/30/13 - $58.18
52 Week Low
07/25/12 - $41.67
Market Cap
10.5B
Average Volume 10 Days
1.3M
EPS TTM
$0.91
Shares Outstanding
205.9M
EX-Date
--
P/E TM
56.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for CATAMARAN CORP (CTRX)

Related News

No related news articles were found.

catamaran corp (CTRX) Related Businessweek News

No Related Businessweek News Found

catamaran corp (CTRX) Details

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Its PBM services include electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail and specialty pharmacy claims management, Medicare Part D services, benefit design consultation, preferred drug management programs, drug review and analysis, consulting services, data access, and reporting and information analysis. The company offers RxCLAIM, an online transaction processing system to provide online adjudication of third-party prescription drug claims at the point of service, as well as payment and billing support and real-time functionality for updating benefit, price, member, provider, and drug details. It also provides RxBUILDER, a Web-based interface for formulary creation and maintenance; RxPORTAL, which allows customers to interact with the patient’s formulary and drug history; and RxAUTH, a prior authorization (PA) management solution for automating PA process. In addition, the company offers RxMAX, a rebate management system designed to assist health plans in managing their relationships with pharmaceutical manufacturers; Zynchros, which provides a suite of formulary management tools; and RxTRACK, a data warehouse and analysis system. It serves various organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, retail pharmacy chains, self-insured employer groups, unions, third party health care plan administrators, and state and federal government entities. The company was formerly known as SXC Health Solutions Corp. and changed its name to Catamaran Corporation in July 2012. Catamaran Corporation was founded in 1993 and is headquartered in Lisle, Illinois.

3,300 Employees
Last Reported Date: 03/1/13
Founded in 1993

catamaran corp (CTRX) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $875.0K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $525.0K
Executive Vice President of Pharmacy Operatio...
Total Annual Compensation: $370.0K
Chief Technology Officer and Executive Vice P...
Total Annual Compensation: $311.0K
Senior Vice President, Corporate Secretary an...
Total Annual Compensation: $275.0K
Compensation as of Fiscal Year 2012.

catamaran corp (CTRX) Key Developments

Catamaran Corporation Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2013; Reaffirms Earnings Guidance for the Year 2013

Catamaran Corporation announced unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company's revenue increased 88% on a year over year basis to $3.2 billion, compared to $1.7 billion in the first quarter of 2012. The increase in revenue is primarily due to the recent merger with Catalyst, which was completed on July 2, 2012, as well as increased prescription claim volume as a result of implementation of new customer contracts in 2013. EBITDA increased 164% to $143.5 million in the quarter, compared to $54.4 million in the first quarter of 2012. The EBITDA growth was due to additional business generated from the recent merger with Catalyst and the associated synergies, as well as new contract implementations, offset by increased costs due to additional resources added to support the growth of the PBM segment. Net income attributable to the company was $51.4 million or $0.25 per diluted share in the quarter, compared to $26.3 million, or $0.21 per diluted share in the first quarter of 2012. Net income attributable to the company increased during the quarter compared to first quarter of 2012 due to increased revenues and operating income as a result of the recent merger with Catalyst and other new customer implementations during 2013. Non-GAAP net income attributable to the company was $86.99 million or $0.42 per diluted share compared with $33.2 million or $0.26 per diluted share a year ago. Cash flow from operations increased 13% to $63.3 million, compared to $56.2 million in the first quarter of 2012. Operating income was $90.9 million compared with $41.0 million a year ago. Income before income taxes was $79.8 million compared with $39.8 million a year ago. Net income was $56.8 million compared with $26.3 million a year ago. Net income was $25.2 million compared with $6.1 million a year ago. For the year 2013, the company re-affirmed revenue guidance in the range of $14.2 billion to $14.6 billion, EBITDA in the range of $660 million to $670 million, GAAP diluted EPS in the range of $1.18 to $1.25, and adjusted diluted EPS in the range of $1.81 to $1.88 (excluding all amortization of intangible assets).

Catamaran Corporation to Report Q1, 2013 Results on May 02, 2013

Catamaran Corporation announced that they will report Q1, 2013 results at 6:00 AM, US Eastern Standard Time on May 02, 2013

Catamaran Corporation, Q1 2013 Earnings Call, May 02, 2013

Catamaran Corporation, Q1 2013 Earnings Call, May 02, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CTRX:US $50.98 USD -1.40

CTRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aetna Inc $60.04 USD +0.51
BioScrip Inc $13.29 USD -0.06
Cigna Corp $67.90 USD +0.54
Express Scripts Holding Co $61.87 USD +1.17
HMS Holdings Corp $25.59 USD +0.17
View Industry Companies
 

Industry Analysis

CTRX

Industry Average

Valuation CTRX Industry Range
Price/Earnings 69.4x
Price/Sales 0.9x
Price/Book 2.3x
Price/Cash Flow 33.2x
TEV/Sales 0.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CATAMARAN CORP, please visit www.catamaranrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.